InhibitorSelect Akt/PI 3-K/mTOR Signaling Pathway Inhibitor Panel

A panel of 12 highly potent and selective kinase inhibitors and a negative control useful for the study of Akt/PI 3-K/mTOR signaling pathway. This panel contains the following inhibitors: 1 mg of Akt Inhibitor IV (Cat. No. 124011); 1 mg of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No.124018); 5 mg of LY-294002 (Cat. No. 440202); 1 mg of LY 303511 (Cat. No. 440203); 5 mg of PDK1/Akt/Flt Dual Pathway Inhibitor (Cat. No. 521275); 1 mg of PI-103 (Cat. No. 528100); 5 mg of PI 3-Kγ Inhibitor (Cat. No. 528106); 5 mg of PI 3-Kγ Inhibitor II (Cat. No. 528108); 5 mg of PI 3-Kα Inhibitor IV (Cat. No. 528111); 5 mg of PI 3-Kα Inhibitor VIII (Cat. No. 528116); 100 µg of Rapamycin (Cat. No. 553210); 500 µg of Ro-31-8220 (Cat. No. 557520); and 1 mg of Wortmannin (Cat. No. 681675). Also provided is 15 ml of anhydrous DMSO. Supplied with a data sheet.

Packaged under inert gas

Following reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C.

Please refer to information provided on the CD for reconstitution information of individual inhibitors.

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Toxicity: Multiple Toxicity Values, refer to MSDS (O)